References
- Burney PGJ. Asthma: epidemiology. Br Med Bull 1992; 48: 10–22
- Sears MR, Taylor DR, Print CG, Lake DC, Li QQ, Flannery EM, Yates DM, Lucas MK, Herbison GP. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336: 1391–1396
- Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, Boivin JF, McNutt M, Buist AS, Rebuck AS. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326(8)560–561
- Suissa S, Ernst P, Boivin JF, Horwitz RI, Habbick B, Cockroft D, Blais L, McNutt M, Buist S, Spitzer WO. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med 1994; 149: 604–610
- Peters MJ, Adcock IM, Brown CR, Barnes PJ. Beta-adrenoreceptor agonists interfere with glucocorticoid receptor DNA-binding in the rat lung. Eur J Pharmacol (Mol Pharm) 1995; 289: 275–281
- Barnes PJ, Pedersen S. Efficacity and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 1993; 120: 1053–1058
- Church MK, Hiroi J. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by antiallergic drugs and salbutamol. Br J Pharmacol 1987; 90: 421–429
- Dennis SM, Sharp SJ, Vickers MR, Frost CD, Crompton GK, Barnes PJ, Lee TH. Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Lancet 2000; 355: 1675–1679
- Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Reinikainen K, Selroos O. Comparison of a beta-2-agonist, terbutaline, with an inhaled corticosteroid, budenoside, in newly detected asthma. N Engl J Med 1991; 325: 388–392
- Wong CS, Wahedna I, Pavord ID, Tattersfield AE. Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge. Am J Respir Crit Care Med 1994; 150: 1268–1273
- Cockcroft DW, Swystun VA, Bhagat R. Interaction of inhaled β2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine. Am J Respir Crit Care Med 1995; 152: 1485–1489
- Adcock IM, Stevens DA, Barnes PJ. Interactions of glucocorticoids and β2-agonists. Eur Respir J 1996; 9(1)160–168
- Hancox RJ, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Wong CS, Taylor DR. Randomised trial of an inhaled β2 agonist, inhaled corticosteroid and their combination in the treatment of asthma. Thorax 1999; 54: 482–487
- Wong B, Dolovich J, Ramsdale EH, O’Byrne P, Gontovnick JA, Denburg A, Hargreave FE. Formoterol compared with beclomethasone and placebo on allergen-induced asthmatic responses. Am Rev Respir Dis 1992; 146: 1156–1160
- Barnes PJ. Nitric oxide and airways. Eur Respir J 1993; 6: 163–165
- Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, (15 N) nitrate in biological fluids. Anal Biochem 1982; 126: 131–138
- Walker JB. Creatine: Biosynthesis, regulation and function. Adv Enzymol 1979; 50: 177–242
- Albina JE, Mills CD, Henry WL, Caldwell MD. Temporal expression of different pathways of L-arginine metabolism in healing wounds. J Immunol 1990; 144: 3877–3880
- Giroux M, Ferrières J. Serum nitrates and creatinine in workers exposed to atmospheric nitrogen oxides and ammonia. Sci total environ 1998; 217: 265–269
- Buga GM, Griescavage JM, Rogers NE, Ignarro LJ. Negative feed back regulation of endothelial cell function by nitric oxide. Circ Res 1993; 73: 808–812
- The childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343: 1054–1063